Oatly Group AB, Similarweb Ltd., Iovance Biotherapeutics, Inc. and others have been slumping.
Markets were up yesterday; Nasdaq closed the day at 11,300, having gained 0.99%. S&P 500 ended the session at 4,027.26 after a 0.59% gain.
Meanwhile, United States Crude Oil Inventories improved upon its previous reading of -5.4 million with a new data release of -3.69 million.
What is a downtrend?
A trend is the overall direction of a market or an asset's trading price over a certain period. A downtrend is when the price is generally pointing downwards; there can be certain periods of time when the price increases, yet the trend remains in a downward direction.
Descends for 8 days and losing 34.69%, Bearish mood pushes Oatly to session low of $1.58
Oatly Group AB's downtrend has seen it decline 34.69% in 8 days yesterday's session continued the recent downtrend: pronounced bearish sentiment in the market pushed the dairy alternative producer into a notable 4.19% slide yesterday, falling 7 cents and ultimately closing at $1.6. Daily trading volume (4.64 million shares) was slightly greater than the current multiday average of 4.19 million.
Continuing a 6 day nosedive: Risk-off mood drags Similarweb 1.09% lower
Similarweb has lost 31.78% over the last 6 days. more of the same from yesterday's session: grinding lower but with no clear-cut direction, the US web analytics company closed the session at $4.53 after forming a distinct $4.45 – $4.63 range. The day's trading volume totalled 74,171 shares — lower than the 21-day average of 172,321.
Descends for 8 days and shedding 29.95%: Iovance Biotherapeutics sheds 0.96% within $6.06 to $6.39 daily range
More of the same from yesterday's session: grinding lower but with no clear-cut direction, the Californian biopharmaceutical startup closed the session at $6.22 after forming a distinct $6.06 – $6.39 range. Iovance Biotherapeutics's downtrend has seen it decline 29.95% in 8 days the volume of trade was 3.33 million shares, close to the daily average of 3.34 million shares.
Iovance Biotherapeutics has a market cap of $981.52 million with an average daily trading volume of 3.34 million shares. The US biotech pioneer is now trading 46.78% below its 3-month high of $20.16. Trending downwards for around 3 months.